They An example of a short-acting GLP-1 RA approved for use in the United States is exenatide, which is injected subcutaneously within 60 minutes prior to morning and evening meals (or before the two main meals of the day, approximately 6 or more hours apart)
Recommend a baseline ophthalmologic exam, particularly for diabetic patients or those with vision complaints
Personal health history plays an important role in determining if someone should be prescribed a GLP-1, which is why its important that anyone considering weight loss drugs starts with a conversation with their primary care provider (PCP)
They improve blood glucose control, encourage weight loss, lower blood pressure, enhance lipid profiles, and have anti-inflammatory and vascular-protective properties
[DOI] [PMC free article] [PubMed] [Google Scholar] Tang T
Methods note on the ~0.56% per year figure cited in this episode: the Santi paper does not report a single percentage rate